PT-141 is a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound acts by activating specific receptors within the body, leading to enhanced sexual performance. Preclinical studies have suggested that PT-141 could significantly address a spectrum of sexual dysfunctions in both